Associations of a metabolic syndrome severity score with coronary heart disease and diabetes in fasting vs. non-fasting individuals

被引:11
|
作者
DeBoer, Mark D. [1 ]
Filipp, Stephanie L. [2 ]
Gurka, Matthew J. [2 ]
机构
[1] Univ Virginia, Dept Pediat, Div Pediat Endocrinol, POB 800386, Charlottesville, VA 22908 USA
[2] Univ Florida, Coll Med, Dept Hlth Outcomes & Biomed Informat, Gainesville, FL 32608 USA
基金
美国国家卫生研究院;
关键词
Cardiovascular disease; Diabetes; Metabolic syndrome; Risk; Fasting; LIPOPROTEIN CHOLESTEROL LEVELS; ATHEROSCLEROSIS RISK; INDEPENDENT ASSOCIATIONS; LIPID-LEVELS; INSULIN; COMMUNITIES; SEX; TRIGLYCERIDES; ABILITY;
D O I
10.1016/j.numecd.2019.08.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Many traditional assessments of risk for coronary heart disease (CHD) and diabetes require laboratory studies performed after an 8-h fast. We assessed whether metabolic-syndrome (MetS) severity would remain linked to future CHD and diabetes even when assessed from non-fasting samples. Methods and results: Participants in the Atherosclerosis Risk in Communities study were assessed at 4 visits and followed for 20-years of adjudicated CHD outcomes. We used Cox proportional-hazard models (for 20-year CHD outcomes) and logistic regression (for 9-year diabetes outcomes) to compare incident disease risk associated with a race/ethnicity-specific MetS-severity Z-score (MetS-Z) calculated in participants who were fasting (>8 h) or non-fasting. All analyses were adjusted for sex, race, education, income and smoking. MetS Z-scores were overall similar between participants who were always fasting vs. those non-fasting at Visits 1-3 (all values -0.1 to 0.4), while MetS-Z for participants who were non-fasting at Visit-4 were higher at each visit. Baseline MetS-Z was linked to future CHD when calculated from both fasting and non-fasting measurements, with hazard ratio (HR) for fasting MetS-Z 1.53 (95% confidence interval [CI] 1.42,1.66) and for non-fasting 1.28 (CI 1.08, 1.51). MetS-Z at Visit-1 also remained linked to future diabetes when measured from non-fasting samples, with odds ratio for fasting MetS-Z 3.10 (CI 2.88, 3.35) and for non-fasting 1.92 (CI 1.05, 3.51). Conclusions: MetS-Z remained linked to future CHD and diabetes when assessed from non-fasting samples. A score such as this may allow for identification of at-risk individuals and serve as a motivation toward interventions to reduce risk. (C) 2019 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:92 / 98
页数:7
相关论文
共 50 条
  • [1] Coronary heart disease in individuals with diabetes, impaired fasting and normal fasting glucose
    Sayeed, MA
    Mahtab, H
    Mahtab, H
    Khanam, PA
    Banu, A
    Rashid, MA
    Khan, AKA
    [J]. DIABETOLOGIA, 2004, 47 : A118 - A118
  • [2] Non-fasting lipid level in Chinese patients with coronary heart disease
    Chen, Yanqiao
    Ling, Liu
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C102 - C102
  • [3] Metabolic Syndrome in Fasting and Non-Fasting Participants: The UAE Healthy Future Study
    Mezhal, Fatima
    Ahmad, Amar
    Abdulle, Abdishakur
    Leinberger-Jabari, Andrea
    Oulhaj, Abderrahim
    AlJunaibi, Abdulla
    Alnaeemi, Abdulla
    Al Dhaheri, Ayesha S.
    AlZaabi, Eiman
    Al-Maskari, Fatma
    AlAnouti, Fatme
    Alsafar, Habiba
    Alkaabi, Juma
    Wareth, Laila Abdel
    Aljaber, Mai
    Kazim, Marina
    Alblooshi, Manal
    Al-Houqani, Mohammad
    Ali, Mohammad Hag
    Oumeziane, Naima
    El-Shahawy, Omar
    Al-Rifai, Rami H.
    Sherman, Scott
    Shah, Syed M.
    Loney, Tom
    Almahmeed, Wael
    Idaghdour, Youssef
    Ahmed, Luai A.
    Ali, Raghib
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (21)
  • [4] The use of fasting vs. non-fasting triglyceride concentration for estimating the prevalence of high LDL-cholesterol and metabolic syndrome in population surveys
    Sundvall, Jouko
    Leiviska, Jaana
    Laatikainen, Tiina
    Peltonen, Markku
    Salomaa, Veikko
    Vanhala, Mauno
    Korpi-Hyovalti, Eeva
    Lauronen, Jukka
    Alfthan, Georg
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2011, 11
  • [5] The use of fasting vs. non-fasting triglyceride concentration for estimating the prevalence of high LDL-cholesterol and metabolic syndrome in population surveys
    Jouko Sundvall
    Jaana Leiviskä
    Tiina Laatikainen
    Markku Peltonen
    Veikko Salomaa
    Mauno Vanhala
    Eeva Korpi-Hyövälti
    Jukka Lauronen
    Georg Alfthan
    [J]. BMC Medical Research Methodology, 11
  • [6] The Role of Fasting LDL-C Levels in Their Non-fasting Reduction in Patients With Coronary Heart Disease
    Lin, Qiuzhen
    Fu, Yan
    Zang, Xue Yan
    Liu, Qiming
    Liu, Ling
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [7] Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults
    Altan Onat
    Günay Can
    Gökhan Çiçek
    Erkan Ayhan
    Yüksel Doğan
    Hasan Kaya
    [J]. Acta Diabetologica, 2013, 50 : 519 - 528
  • [8] Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults
    Onat, Altan
    Can, Gunay
    Cicek, Gokhan
    Ayhan, Erkan
    Dogan, Yuksel
    Kaya, Hasan
    [J]. ACTA DIABETOLOGICA, 2013, 50 (04) : 519 - 528
  • [9] Ability of non-fasting and fasting triglycerides to predict coronary artery disease in lupus patients
    Touma, Zahi
    Gladman, Dafna D.
    Ibanez, Dominique
    Urowitz, Murray B.
    [J]. RHEUMATOLOGY, 2012, 51 (03) : 528 - 534
  • [10] The effect of fasting vs. non-fasting samples on four homogenous LDL-cholesterol assays.
    Anderson, FP
    Jayne, EC
    Ethridge, SF
    Miller, WG
    Waymack, PP
    Karageorge, LS
    [J]. CLINICAL CHEMISTRY, 2000, 46 (06) : A106 - A106